# Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

> **NCT00872417** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College** · enrollment: 750 (estimated)

## Conditions studied

- Acquired Immune Deficiency Syndrome
- HIV Infections

## Interventions

- **DRUG:** first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT)
- **DRUG:** second line ARV therapy (3TC+TDF+LPV/RTV)

## Key facts

- **NCT ID:** NCT00872417
- **Lead sponsor:** Peking Union Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2009-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872417, "Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00872417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*